Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non-inferiority, phase III trial.

SH, Chen; TM, Yuan; J, Zhang; H, Bai; M, Tian; CX, Pan; HG, Bao; XJ, Jin; FH, Ji; TD, Zhong; Q, Wang; JR, Lv; S, Wang; YJ, Li; YH, Yu; AL, Luo; XK, Li; S, Min; L, Li; XH, Zou; YG, Huang

doi:10.1111/jgh.15188

Public

Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non-inferiority, phase III trial.

Shared by NobleBlocks on Jul 24, 2020 • 12:00 AM UTC

Authors:

Chen SH

Yuan TM

Zhang J

Abstract

Background and aim Remimazolam tosilate (RT) is a new short-acting GABA(A) receptor agonist, having potential to be an effective option for procedural sedation. Here, we aimed to compare the efficacy and safety of RT with propofol in patients undergoing upper gastrointestinal endoscopy.Methods This ...

Subject

Benzodiazepine

Endoscopic Sedation

Upper Gastrointestinal Endoscopy

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!